Arteris Secures Edge AI Customer Win with Blaize, Expanding Its FlexNoC 5 Adoption

AIP
November 11, 2025

Arteris, a semiconductor IP provider, announced that Blaize, a developer of edge and hybrid AI platforms, has adopted the company’s FlexNoC 5 interconnect IP. The partnership, announced on November 11 2025, marks a new customer win that expands Arteris’ footprint in the growing edge‑AI market.

Blaize’s programmable processor architecture is engineered for smart‑vision, industrial‑sensing, and language‑understanding workloads that run at the edge. By integrating FlexNoC 5, Blaize can move data across its chip more efficiently, boosting throughput, reducing latency, and cutting power consumption—key metrics for real‑time, multimodal inference.

Arteris’ recent earnings show revenue growth to $17.4 million in Q3 2025, up from $16.5 million in Q2, driven by expanding licensing and royalty contracts. The new Blaize win adds to the company’s annual contract value and remaining performance obligations, reinforcing a pipeline that has been growing even as net losses narrow.

The partnership aligns with a broader industry shift toward specialized IP that accelerates AI‑edge device development. Demand for low‑latency, power‑efficient interconnects is rising as manufacturers push AI workloads into automotive, communications, and industrial applications—sectors where Arteris already serves a diverse customer base.

K. Charles Janac, Arteris’ president and CEO, said the FlexNoC 5 integration demonstrates the company’s commitment to enabling customers like Blaize to deliver cutting‑edge AI solutions. He added that the win underscores Arteris’ position as a leading interconnect IP provider and signals continued momentum in the edge‑AI space.

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.